Modelling heat-induced radiosensitization: Clinical implications

R. J. Myerson, J. L. Roti Roti, E. G. Moros, W. L. Straube, M. Xu

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations


Clinically achievable minimum tumour temperatures are in the order of about 41°C. Therefore, it is important to evaluate mechanisms by which temperatures in this range might enhance cytotoxicity. Previous in vitro studies have demonstrated that 1-4 h (depending on the sequencing of modalities) of heating at 41°C produces substantial heat-induced radiosensitization with little or no cell killing by heat alone. The increased radiation sensitivity is best modelled as a change in the single hit, α, parameter (with no significant effect on the two-hit parameter, β) of the cell survival curve. The implications of heat-induced radiosensitization being mediated by a change in α on the traditional thermal enhancement ratio (for various radiation doses/fraction and α/β) are reviewed. Response rates for a cohort of 60 patients enrolled on a prospective thermal dose escalation study are modelled assuming that the thermal dose dependence of heat-induced radiosensitization is modulated by a heat-induced Δα. The clinical data are fitted with Δα about 0.05-0.1 Gy -1. Randomized trials reported in the literature and the implication for the design of future prospective trials are reviewed in light of these observations.

Original languageEnglish
Pages (from-to)201-212
Number of pages12
JournalInternational Journal of Hyperthermia
Issue number2
StatePublished - Mar 2004


  • Heat-induced radiosensitization
  • Hyperthermia
  • Radiation therapy


Dive into the research topics of 'Modelling heat-induced radiosensitization: Clinical implications'. Together they form a unique fingerprint.

Cite this